Terumo Corporation
Terumo Corporation (TRUMY) Stock Competitors & Peer Comparison
See (TRUMY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TRUMY | $12.82 | +1.58% | 19B | 22.98 | $0.56 | +1.44% |
| SRTOY | $19.50 | +3.00% | 189.7B | 60.94 | $0.32 | +0.41% |
| ESLOY | $106.10 | +3.27% | 97.6B | 36.50 | $2.91 | +2.13% |
| ESLOF | $213.15 | +7.25% | 95.4B | 35.33 | $5.83 | +2.28% |
| SOAGY | $52.66 | -0.28% | 77.6B | 96.55 | $0.55 | +0.32% |
| HOCPF | $190.15 | +7.31% | 63.8B | 40.81 | $4.66 | +1.01% |
| HOCPY | $185.00 | +3.23% | 62B | 39.67 | $4.66 | +0.93% |
| RSMDF | $24.89 | +0.00% | 36.3B | 23.93 | $1.04 | +1.11% |
| MECNY | $88.63 | +0.00% | 26.9B | N/A | N/A | N/A |
| TRUMF | $13.45 | +1.89% | 19.8B | 24.45 | $0.55 | +1.46% |
Stock Comparison
TRUMY vs SRTOY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SRTOY has a market cap of 189.7B. Regarding current trading prices, TRUMY is priced at $12.82, while SRTOY trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SRTOY's P/E ratio is 60.94. In terms of profitability, TRUMY's ROE is +0.09%, compared to SRTOY's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to SRTOY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SRTOY's competition here
TRUMY vs ESLOY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, ESLOY has a market cap of 97.6B. Regarding current trading prices, TRUMY is priced at $12.82, while ESLOY trades at $106.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas ESLOY's P/E ratio is 36.50. In terms of profitability, TRUMY's ROE is +0.09%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check ESLOY's competition here
TRUMY vs ESLOF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, ESLOF has a market cap of 95.4B. Regarding current trading prices, TRUMY is priced at $12.82, while ESLOF trades at $213.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas ESLOF's P/E ratio is 35.33. In terms of profitability, TRUMY's ROE is +0.09%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check ESLOF's competition here
TRUMY vs SOAGY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SOAGY has a market cap of 77.6B. Regarding current trading prices, TRUMY is priced at $12.82, while SOAGY trades at $52.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SOAGY's P/E ratio is 96.55. In terms of profitability, TRUMY's ROE is +0.09%, compared to SOAGY's ROE of +0.06%. Regarding short-term risk, TRUMY is more volatile compared to SOAGY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check SOAGY's competition here
TRUMY vs HOCPF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, HOCPF has a market cap of 63.8B. Regarding current trading prices, TRUMY is priced at $12.82, while HOCPF trades at $190.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas HOCPF's P/E ratio is 40.81. In terms of profitability, TRUMY's ROE is +0.09%, compared to HOCPF's ROE of +0.25%. Regarding short-term risk, TRUMY is more volatile compared to HOCPF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check HOCPF's competition here
TRUMY vs HOCPY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, HOCPY has a market cap of 62B. Regarding current trading prices, TRUMY is priced at $12.82, while HOCPY trades at $185.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas HOCPY's P/E ratio is 39.67. In terms of profitability, TRUMY's ROE is +0.09%, compared to HOCPY's ROE of +0.25%. Regarding short-term risk, TRUMY is more volatile compared to HOCPY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check HOCPY's competition here
TRUMY vs RSMDF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, RSMDF has a market cap of 36.3B. Regarding current trading prices, TRUMY is priced at $12.82, while RSMDF trades at $24.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas RSMDF's P/E ratio is 23.93. In terms of profitability, TRUMY's ROE is +0.09%, compared to RSMDF's ROE of +0.24%. Regarding short-term risk, TRUMY is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check RSMDF's competition here
TRUMY vs MECNY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, MECNY has a market cap of 26.9B. Regarding current trading prices, TRUMY is priced at $12.82, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas MECNY's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to MECNY's ROE of +0.02%. Regarding short-term risk, TRUMY is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check MECNY's competition here
TRUMY vs TRUMF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, TRUMF has a market cap of 19.8B. Regarding current trading prices, TRUMY is priced at $12.82, while TRUMF trades at $13.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas TRUMF's P/E ratio is 24.45. In terms of profitability, TRUMY's ROE is +0.09%, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, TRUMY is more volatile compared to TRUMF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check TRUMF's competition here
TRUMY vs SDMHF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SDMHF has a market cap of 18.5B. Regarding current trading prices, TRUMY is priced at $12.82, while SDMHF trades at $190.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SDMHF's P/E ratio is 58.64. In terms of profitability, TRUMY's ROE is +0.09%, compared to SDMHF's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to SDMHF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SDMHF's competition here
TRUMY vs SAUHY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SAUHY has a market cap of 18B. Regarding current trading prices, TRUMY is priced at $12.82, while SAUHY trades at $11.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SAUHY's P/E ratio is 40.32. In terms of profitability, TRUMY's ROE is +0.09%, compared to SAUHY's ROE of +0.17%. Regarding short-term risk, TRUMY is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SAUHY's competition here
TRUMY vs SAUHF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SAUHF has a market cap of 17.5B. Regarding current trading prices, TRUMY is priced at $12.82, while SAUHF trades at $109.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SAUHF's P/E ratio is 38.41. In terms of profitability, TRUMY's ROE is +0.09%, compared to SAUHF's ROE of +0.17%. Regarding short-term risk, TRUMY is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SAUHF's competition here
TRUMY vs SUVPF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SUVPF has a market cap of 17.3B. Regarding current trading prices, TRUMY is priced at $12.82, while SUVPF trades at $250.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SUVPF's P/E ratio is 91.24. In terms of profitability, TRUMY's ROE is +0.09%, compared to SUVPF's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to SUVPF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SUVPF's competition here
TRUMY vs SSSGY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SSSGY has a market cap of 14.9B. Regarding current trading prices, TRUMY is priced at $12.82, while SSSGY trades at $43.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SSSGY's P/E ratio is 78.54. In terms of profitability, TRUMY's ROE is +0.09%, compared to SSSGY's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to SSSGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SSSGY's competition here
TRUMY vs SARTF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SARTF has a market cap of 14.7B. Regarding current trading prices, TRUMY is priced at $12.82, while SARTF trades at $212.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SARTF's P/E ratio is 76.94. In terms of profitability, TRUMY's ROE is +0.09%, compared to SARTF's ROE of +0.06%. Regarding short-term risk, TRUMY is more volatile compared to SARTF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check SARTF's competition here
TRUMY vs CLPBY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, CLPBY has a market cap of 14.4B. Regarding current trading prices, TRUMY is priced at $12.82, while CLPBY trades at $6.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas CLPBY's P/E ratio is 22.82. In terms of profitability, TRUMY's ROE is +0.09%, compared to CLPBY's ROE of +0.25%. Regarding short-term risk, TRUMY and CLPBY have similar daily volatility (1.25).Check CLPBY's competition here
TRUMY vs FSPKF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, FSPKF has a market cap of 13.5B. Regarding current trading prices, TRUMY is priced at $12.82, while FSPKF trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas FSPKF's P/E ratio is 52.32. In terms of profitability, TRUMY's ROE is +0.09%, compared to FSPKF's ROE of +0.30%. Regarding short-term risk, TRUMY is more volatile compared to FSPKF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check FSPKF's competition here
TRUMY vs CLPBF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, CLPBF has a market cap of 13.4B. Regarding current trading prices, TRUMY is priced at $12.82, while CLPBF trades at $64.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas CLPBF's P/E ratio is 23.28. In terms of profitability, TRUMY's ROE is +0.09%, compared to CLPBF's ROE of +0.25%. Regarding short-term risk, TRUMY is more volatile compared to CLPBF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check CLPBF's competition here
TRUMY vs OCPNF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, OCPNF has a market cap of 10.4B. Regarding current trading prices, TRUMY is priced at $12.82, while OCPNF trades at $9.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas OCPNF's P/E ratio is 17.57. In terms of profitability, TRUMY's ROE is +0.09%, compared to OCPNF's ROE of +0.11%. Regarding short-term risk, TRUMY is less volatile compared to OCPNF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check OCPNF's competition here
TRUMY vs CNVVF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, CNVVF has a market cap of 5.8B. Regarding current trading prices, TRUMY is priced at $12.82, while CNVVF trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas CNVVF's P/E ratio is 33.22. In terms of profitability, TRUMY's ROE is +0.09%, compared to CNVVF's ROE of +0.11%. Regarding short-term risk, TRUMY is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check CNVVF's competition here
TRUMY vs AHICF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, AHICF has a market cap of 5.7B. Regarding current trading prices, TRUMY is priced at $12.82, while AHICF trades at $21.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas AHICF's P/E ratio is 51.48. In terms of profitability, TRUMY's ROE is +0.09%, compared to AHICF's ROE of +0.12%. Regarding short-term risk, TRUMY is less volatile compared to AHICF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check AHICF's competition here
TRUMY vs CNVVY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, CNVVY has a market cap of 5.7B. Regarding current trading prices, TRUMY is priced at $12.82, while CNVVY trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas CNVVY's P/E ratio is 34.47. In terms of profitability, TRUMY's ROE is +0.09%, compared to CNVVY's ROE of +0.10%. Regarding short-term risk, TRUMY is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check CNVVY's competition here
TRUMY vs SSMXY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SSMXY has a market cap of 5.3B. Regarding current trading prices, TRUMY is priced at $12.82, while SSMXY trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SSMXY's P/E ratio is 18.19. In terms of profitability, TRUMY's ROE is +0.09%, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, TRUMY is more volatile compared to SSMXY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check SSMXY's competition here
TRUMY vs SSMXF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SSMXF has a market cap of 5.3B. Regarding current trading prices, TRUMY is priced at $12.82, while SSMXF trades at $8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SSMXF's P/E ratio is 17.94. In terms of profitability, TRUMY's ROE is +0.09%, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, TRUMY is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SSMXF's competition here
TRUMY vs ADDLF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, TRUMY is priced at $12.82, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, TRUMY's ROE is +0.09%, compared to ADDLF's ROE of +0.11%. Regarding short-term risk, TRUMY is more volatile compared to ADDLF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check ADDLF's competition here
TRUMY vs YPHDF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, YPHDF has a market cap of 4.8B. Regarding current trading prices, TRUMY is priced at $12.82, while YPHDF trades at $354.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas YPHDF's P/E ratio is 19.73. In terms of profitability, TRUMY's ROE is +0.09%, compared to YPHDF's ROE of +0.27%. Regarding short-term risk, TRUMY is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check YPHDF's competition here
TRUMY vs FLMNF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, FLMNF has a market cap of 4.3B. Regarding current trading prices, TRUMY is priced at $12.82, while FLMNF trades at $50.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas FLMNF's P/E ratio is 19.98. In terms of profitability, TRUMY's ROE is +0.09%, compared to FLMNF's ROE of +0.22%. Regarding short-term risk, TRUMY is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check FLMNF's competition here
TRUMY vs FLMNY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, FLMNY has a market cap of 4.2B. Regarding current trading prices, TRUMY is priced at $12.82, while FLMNY trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas FLMNY's P/E ratio is 19.48. In terms of profitability, TRUMY's ROE is +0.09%, compared to FLMNY's ROE of +0.21%. Regarding short-term risk, TRUMY is less volatile compared to FLMNY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check FLMNY's competition here
TRUMY vs ANSLF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, ANSLF has a market cap of 3.2B. Regarding current trading prices, TRUMY is priced at $12.82, while ANSLF trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas ANSLF's P/E ratio is 32.49. In terms of profitability, TRUMY's ROE is +0.09%, compared to ANSLF's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check ANSLF's competition here
TRUMY vs ANSLY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, ANSLY has a market cap of 3B. Regarding current trading prices, TRUMY is priced at $12.82, while ANSLY trades at $83.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas ANSLY's P/E ratio is 22.45. In terms of profitability, TRUMY's ROE is +0.09%, compared to ANSLY's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to ANSLY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check ANSLY's competition here
TRUMY vs CZMWY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, CZMWY has a market cap of 2.7B. Regarding current trading prices, TRUMY is priced at $12.82, while CZMWY trades at $30.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas CZMWY's P/E ratio is 16.22. In terms of profitability, TRUMY's ROE is +0.09%, compared to CZMWY's ROE of +0.06%. Regarding short-term risk, TRUMY is more volatile compared to CZMWY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check CZMWY's competition here
TRUMY vs CZMWF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, CZMWF has a market cap of 2.7B. Regarding current trading prices, TRUMY is priced at $12.82, while CZMWF trades at $30.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas CZMWF's P/E ratio is 16.12. In terms of profitability, TRUMY's ROE is +0.09%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check CZMWF's competition here
TRUMY vs EKTAY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, EKTAY has a market cap of 2.3B. Regarding current trading prices, TRUMY is priced at $12.82, while EKTAY trades at $5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas EKTAY's P/E ratio is -597.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to EKTAY's ROE of -0.00%. Regarding short-term risk, TRUMY is less volatile compared to EKTAY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check EKTAY's competition here
TRUMY vs TCGGY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, TCGGY has a market cap of 2.3B. Regarding current trading prices, TRUMY is priced at $12.82, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas TCGGY's P/E ratio is 27.27. In terms of profitability, TRUMY's ROE is +0.09%, compared to TCGGY's ROE of -0.09%. Regarding short-term risk, TRUMY is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check TCGGY's competition here
TRUMY vs EKTAF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, EKTAF has a market cap of 2.2B. Regarding current trading prices, TRUMY is priced at $12.82, while EKTAF trades at $6.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas EKTAF's P/E ratio is -606.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to EKTAF's ROE of -0.00%. Regarding short-term risk, TRUMY is more volatile compared to EKTAF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check EKTAF's competition here
TRUMY vs TCHBF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, TCHBF has a market cap of 2.2B. Regarding current trading prices, TRUMY is priced at $12.82, while TCHBF trades at $175.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas TCHBF's P/E ratio is -15.88. In terms of profitability, TRUMY's ROE is +0.09%, compared to TCHBF's ROE of -0.09%. Regarding short-term risk, TRUMY is less volatile compared to TCHBF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check TCHBF's competition here
TRUMY vs SHWGY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SHWGY has a market cap of 2B. Regarding current trading prices, TRUMY is priced at $12.82, while SHWGY trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SHWGY's P/E ratio is 8.75. In terms of profitability, TRUMY's ROE is +0.09%, compared to SHWGY's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SHWGY's competition here
TRUMY vs SHWGF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SHWGF has a market cap of 2B. Regarding current trading prices, TRUMY is priced at $12.82, while SHWGF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SHWGF's P/E ratio is 8.80. In terms of profitability, TRUMY's ROE is +0.09%, compared to SHWGF's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to SHWGF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SHWGF's competition here
TRUMY vs NPRRF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, NPRRF has a market cap of 1.6B. Regarding current trading prices, TRUMY is priced at $12.82, while NPRRF trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas NPRRF's P/E ratio is 26.21. In terms of profitability, TRUMY's ROE is +0.09%, compared to NPRRF's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to NPRRF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check NPRRF's competition here
TRUMY vs BOEUF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, TRUMY is priced at $12.82, while BOEUF trades at $24.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas BOEUF's P/E ratio is 81.73. In terms of profitability, TRUMY's ROE is +0.09%, compared to BOEUF's ROE of +0.22%. Regarding short-term risk, TRUMY is less volatile compared to BOEUF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check BOEUF's competition here
TRUMY vs TGLVY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, TGLVY has a market cap of 1.2B. Regarding current trading prices, TRUMY is priced at $12.82, while TGLVY trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas TGLVY's P/E ratio is 31.05. In terms of profitability, TRUMY's ROE is +0.09%, compared to TGLVY's ROE of +0.03%. Regarding short-term risk, TRUMY is less volatile compared to TGLVY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check TGLVY's competition here
TRUMY vs SAFLY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SAFLY has a market cap of 1.2B. Regarding current trading prices, TRUMY is priced at $12.82, while SAFLY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SAFLY's P/E ratio is 14.81. In terms of profitability, TRUMY's ROE is +0.09%, compared to SAFLY's ROE of +0.12%. Regarding short-term risk, TRUMY is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SAFLY's competition here
TRUMY vs BITGF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, TRUMY is priced at $12.82, while BITGF trades at $15.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas BITGF's P/E ratio is 45.50. In terms of profitability, TRUMY's ROE is +0.09%, compared to BITGF's ROE of +0.04%. Regarding short-term risk, TRUMY is more volatile compared to BITGF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check BITGF's competition here
TRUMY vs PBHDF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, PBHDF has a market cap of 1.2B. Regarding current trading prices, TRUMY is priced at $12.82, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, TRUMY's ROE is +0.09%, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check PBHDF's competition here
TRUMY vs TDVXF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, TDVXF has a market cap of 936.7M. Regarding current trading prices, TRUMY is priced at $12.82, while TDVXF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas TDVXF's P/E ratio is 49.30. In terms of profitability, TRUMY's ROE is +0.09%, compared to TDVXF's ROE of +0.32%. Regarding short-term risk, TRUMY is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check TDVXF's competition here
TRUMY vs SAFLF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SAFLF has a market cap of 906.6M. Regarding current trading prices, TRUMY is priced at $12.82, while SAFLF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SAFLF's P/E ratio is 16.50. In terms of profitability, TRUMY's ROE is +0.09%, compared to SAFLF's ROE of +0.12%. Regarding short-term risk, TRUMY is more volatile compared to SAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check SAFLF's competition here
TRUMY vs KSRBF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, KSRBF has a market cap of 841.7M. Regarding current trading prices, TRUMY is priced at $12.82, while KSRBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas KSRBF's P/E ratio is 33.29. In terms of profitability, TRUMY's ROE is +0.09%, compared to KSRBF's ROE of +0.04%. Regarding short-term risk, TRUMY is more volatile compared to KSRBF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check KSRBF's competition here
TRUMY vs HGYMF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, HGYMF has a market cap of 754.4M. Regarding current trading prices, TRUMY is priced at $12.82, while HGYMF trades at $34.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas HGYMF's P/E ratio is 184.16. In terms of profitability, TRUMY's ROE is +0.09%, compared to HGYMF's ROE of +0.00%. Regarding short-term risk, TRUMY is more volatile compared to HGYMF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check HGYMF's competition here
TRUMY vs GRRMF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, GRRMF has a market cap of 713.3M. Regarding current trading prices, TRUMY is priced at $12.82, while GRRMF trades at $20.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas GRRMF's P/E ratio is 25.81. In terms of profitability, TRUMY's ROE is +0.09%, compared to GRRMF's ROE of +0.02%. Regarding short-term risk, TRUMY is less volatile compared to GRRMF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check GRRMF's competition here
TRUMY vs NNCSF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, NNCSF has a market cap of 706.4M. Regarding current trading prices, TRUMY is priced at $12.82, while NNCSF trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas NNCSF's P/E ratio is 47.28. In terms of profitability, TRUMY's ROE is +0.09%, compared to NNCSF's ROE of +0.10%. Regarding short-term risk, TRUMY is more volatile compared to NNCSF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check NNCSF's competition here
TRUMY vs JNDOF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, JNDOF has a market cap of 531.1M. Regarding current trading prices, TRUMY is priced at $12.82, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, TRUMY's ROE is +0.09%, compared to JNDOF's ROE of +0.27%. Regarding short-term risk, TRUMY is more volatile compared to JNDOF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check JNDOF's competition here
TRUMY vs SPMXF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, TRUMY is priced at $12.82, while SPMXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to SPMXF's ROE of -0.07%. Regarding short-term risk, TRUMY is less volatile compared to SPMXF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SPMXF's competition here
TRUMY vs CLHLF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, CLHLF has a market cap of 365.5M. Regarding current trading prices, TRUMY is priced at $12.82, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, TRUMY's ROE is +0.09%, compared to CLHLF's ROE of +0.16%. Regarding short-term risk, TRUMY is more volatile compared to CLHLF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check CLHLF's competition here
TRUMY vs GUERF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, TRUMY is priced at $12.82, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas GUERF's P/E ratio is 8.19. In terms of profitability, TRUMY's ROE is +0.09%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, TRUMY is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check GUERF's competition here
TRUMY vs TSNLF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, TSNLF has a market cap of 265.1M. Regarding current trading prices, TRUMY is priced at $12.82, while TSNLF trades at $5.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas TSNLF's P/E ratio is 25.14. In terms of profitability, TRUMY's ROE is +0.09%, compared to TSNLF's ROE of +0.24%. Regarding short-term risk, TRUMY is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check TSNLF's competition here
TRUMY vs OPSSF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, TRUMY is priced at $12.82, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, TRUMY's ROE is +0.09%, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, TRUMY is more volatile compared to OPSSF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check OPSSF's competition here
TRUMY vs EEOIF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, TRUMY is priced at $12.82, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, TRUMY's ROE is +0.09%, compared to EEOIF's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check EEOIF's competition here
TRUMY vs OTCFF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, OTCFF has a market cap of 21.4M. Regarding current trading prices, TRUMY is priced at $12.82, while OTCFF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas OTCFF's P/E ratio is -13.33. In terms of profitability, TRUMY's ROE is +0.09%, compared to OTCFF's ROE of +1.38%. Regarding short-term risk, TRUMY is more volatile compared to OTCFF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check OTCFF's competition here
TRUMY vs UEEC Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, UEEC has a market cap of 18.1M. Regarding current trading prices, TRUMY is priced at $12.82, while UEEC trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas UEEC's P/E ratio is -7.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to UEEC's ROE of +0.81%. Regarding short-term risk, TRUMY is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check UEEC's competition here
TRUMY vs TUTH Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, TUTH has a market cap of 5.5M. Regarding current trading prices, TRUMY is priced at $12.82, while TUTH trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas TUTH's P/E ratio is -2.18. In terms of profitability, TRUMY's ROE is +0.09%, compared to TUTH's ROE of +0.27%. Regarding short-term risk, TRUMY is less volatile compared to TUTH. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check TUTH's competition here
TRUMY vs BLMHF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, TRUMY is priced at $12.82, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, TRUMY's ROE is +0.09%, compared to BLMHF's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check BLMHF's competition here
TRUMY vs PXMVF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, TRUMY is priced at $12.82, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, TRUMY's ROE is +0.09%, compared to PXMVF's ROE of -6.46%. Regarding short-term risk, TRUMY is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check PXMVF's competition here
TRUMY vs CBSC Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, CBSC has a market cap of 4.5M. Regarding current trading prices, TRUMY is priced at $12.82, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas CBSC's P/E ratio is -4.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to CBSC's ROE of +0.58%. Regarding short-term risk, TRUMY is more volatile compared to CBSC. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check CBSC's competition here
TRUMY vs MCDA Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, MCDA has a market cap of 4.2M. Regarding current trading prices, TRUMY is priced at $12.82, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas MCDA's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to MCDA's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to MCDA. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check MCDA's competition here
TRUMY vs GVDI Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, GVDI has a market cap of 4.2M. Regarding current trading prices, TRUMY is priced at $12.82, while GVDI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas GVDI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, TRUMY is more volatile compared to GVDI. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check GVDI's competition here
TRUMY vs RSCF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, RSCF has a market cap of 3.6M. Regarding current trading prices, TRUMY is priced at $12.82, while RSCF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas RSCF's P/E ratio is -4.20. In terms of profitability, TRUMY's ROE is +0.09%, compared to RSCF's ROE of +0.10%. Regarding short-term risk, TRUMY is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check RSCF's competition here
TRUMY vs NSTGQ Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, TRUMY is priced at $12.82, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check NSTGQ's competition here
TRUMY vs ECIA Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, ECIA has a market cap of 2.5M. Regarding current trading prices, TRUMY is priced at $12.82, while ECIA trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas ECIA's P/E ratio is -6.67. In terms of profitability, TRUMY's ROE is +0.09%, compared to ECIA's ROE of -0.22%. Regarding short-term risk, TRUMY is more volatile compared to ECIA. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check ECIA's competition here
TRUMY vs YBGJ Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, YBGJ has a market cap of 1M. Regarding current trading prices, TRUMY is priced at $12.82, while YBGJ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas YBGJ's P/E ratio is -0.84. In terms of profitability, TRUMY's ROE is +0.09%, compared to YBGJ's ROE of +0.38%. Regarding short-term risk, TRUMY is more volatile compared to YBGJ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check YBGJ's competition here
TRUMY vs OJSY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, OJSY has a market cap of 454.3K. Regarding current trading prices, TRUMY is priced at $12.82, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas OJSY's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to OJSY's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to OJSY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check OJSY's competition here
TRUMY vs PDMI Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, TRUMY is priced at $12.82, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas PDMI's P/E ratio is -0.01. In terms of profitability, TRUMY's ROE is +0.09%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, TRUMY is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check PDMI's competition here
TRUMY vs WHSI Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, TRUMY is priced at $12.82, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas WHSI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, TRUMY is more volatile compared to WHSI. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check WHSI's competition here
TRUMY vs BLFE Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, TRUMY is priced at $12.82, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas BLFE's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to BLFE's ROE of +3.67%. Regarding short-term risk, TRUMY is more volatile compared to BLFE. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check BLFE's competition here
TRUMY vs QTXB Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, TRUMY is priced at $12.82, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas QTXB's P/E ratio is -0.05. In terms of profitability, TRUMY's ROE is +0.09%, compared to QTXB's ROE of +0.19%. Regarding short-term risk, TRUMY is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check QTXB's competition here
TRUMY vs CEOS Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, CEOS has a market cap of 107.7K. Regarding current trading prices, TRUMY is priced at $12.82, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas CEOS's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to CEOS's ROE of +7.33%. Regarding short-term risk, TRUMY is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check CEOS's competition here
TRUMY vs IMTH Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, IMTH has a market cap of 101.7K. Regarding current trading prices, TRUMY is priced at $12.82, while IMTH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas IMTH's P/E ratio is -0.03. In terms of profitability, TRUMY's ROE is +0.09%, compared to IMTH's ROE of -0.60%. Regarding short-term risk, TRUMY is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check IMTH's competition here
TRUMY vs LANZ Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, LANZ has a market cap of 74.5K. Regarding current trading prices, TRUMY is priced at $12.82, while LANZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas LANZ's P/E ratio is 2.70. In terms of profitability, TRUMY's ROE is +0.09%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, TRUMY is less volatile compared to LANZ. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check LANZ's competition here
TRUMY vs GMVDF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, GMVDF has a market cap of 52K. Regarding current trading prices, TRUMY is priced at $12.82, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas GMVDF's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, TRUMY is less volatile compared to GMVDF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check GMVDF's competition here
TRUMY vs REMI Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, REMI has a market cap of 14K. Regarding current trading prices, TRUMY is priced at $12.82, while REMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas REMI's P/E ratio is -0.07. In terms of profitability, TRUMY's ROE is +0.09%, compared to REMI's ROE of -0.11%. Regarding short-term risk, TRUMY is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check REMI's competition here
TRUMY vs MDIT Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, MDIT has a market cap of 8.7K. Regarding current trading prices, TRUMY is priced at $12.82, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas MDIT's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, TRUMY is more volatile compared to MDIT. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check MDIT's competition here
TRUMY vs ASFX Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, ASFX has a market cap of 5.3K. Regarding current trading prices, TRUMY is priced at $12.82, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas ASFX's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to ASFX. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check ASFX's competition here
TRUMY vs DGEN Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, TRUMY is priced at $12.82, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas DGEN's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check DGEN's competition here
TRUMY vs SVSO Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SVSO has a market cap of 2.6K. Regarding current trading prices, TRUMY is priced at $12.82, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SVSO's P/E ratio is -0.01. In terms of profitability, TRUMY's ROE is +0.09%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, TRUMY is more volatile compared to SVSO. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check SVSO's competition here
TRUMY vs LFPI Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, LFPI has a market cap of 2.1K. Regarding current trading prices, TRUMY is priced at $12.82, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas LFPI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, TRUMY is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check LFPI's competition here
TRUMY vs SDCCQ Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SDCCQ has a market cap of 1.3K. Regarding current trading prices, TRUMY is priced at $12.82, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, TRUMY is less volatile compared to SDCCQ. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check SDCCQ's competition here
TRUMY vs INND Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, INND has a market cap of 1.2K. Regarding current trading prices, TRUMY is priced at $12.82, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas INND's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to INND's ROE of -0.01%. Regarding short-term risk, TRUMY is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check INND's competition here
TRUMY vs SEYE Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, TRUMY is priced at $12.82, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SEYE's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to SEYE's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check SEYE's competition here
TRUMY vs BGMD Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, TRUMY is priced at $12.82, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas BGMD's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to BGMD's ROE of +7.47%. Regarding short-term risk, TRUMY is more volatile compared to BGMD. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check BGMD's competition here
TRUMY vs ADLI Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, TRUMY is priced at $12.82, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas ADLI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, TRUMY is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check ADLI's competition here
TRUMY vs VSMD Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, VSMD has a market cap of 802. Regarding current trading prices, TRUMY is priced at $12.82, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas VSMD's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, TRUMY is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check VSMD's competition here
TRUMY vs TEVNF Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, TEVNF has a market cap of 744. Regarding current trading prices, TRUMY is priced at $12.82, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas TEVNF's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, TRUMY is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.Check TEVNF's competition here
TRUMY vs HRAL Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, HRAL has a market cap of 396. Regarding current trading prices, TRUMY is priced at $12.82, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas HRAL's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to HRAL's ROE of +0.21%. Regarding short-term risk, TRUMY is more volatile compared to HRAL. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check HRAL's competition here
TRUMY vs MICRD Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, MICRD has a market cap of 317. Regarding current trading prices, TRUMY is priced at $12.82, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas MICRD's P/E ratio is -0.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, TRUMY is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check MICRD's competition here
TRUMY vs RGBOQ Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, TRUMY is priced at $12.82, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check RGBOQ's competition here
TRUMY vs SECI Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, SECI has a market cap of 31. Regarding current trading prices, TRUMY is priced at $12.82, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas SECI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to SECI's ROE of -0.00%. Regarding short-term risk, TRUMY is more volatile compared to SECI. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check SECI's competition here
TRUMY vs VTEQ Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, TRUMY is priced at $12.82, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to VTEQ's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check VTEQ's competition here
TRUMY vs MEDVD Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, MEDVD has a market cap of 0. Regarding current trading prices, TRUMY is priced at $12.82, while MEDVD trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas MEDVD's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to MEDVD's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to MEDVD. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check MEDVD's competition here
TRUMY vs OCPNY Comparison May 2026
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 19B. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, TRUMY is priced at $12.82, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 22.98, whereas OCPNY's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, TRUMY is more volatile compared to OCPNY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.Check OCPNY's competition here